SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LCI - Lannett Company, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Caruthers who wrote (22)1/11/2007 1:44:10 PM
From: richardred  Read Replies (1) of 81
 
A point was made on the YH LCI board about a former bigger scale deal LCI/SPPI. Generic Cipro deal . I am a SPPI holder also. This was a disappoint. Lots of competition. I however do not want another anthrax scare to get it popular. This deal still might be limited due to competition, but it's a positive. If I remember right from a SPPI 10K the generic had a 2 million in sales. A big disappointment for a brand name drug that once held a billion in sales. I still think it will fare much better than generic Cipro.

This happened (contract MFG) a year after my earilier YH post.
messages.finance.yahoo.com

Maybe will will here more on the Wintec deal soon also?

Re: Bingo -not quite but getting closer (Not rated) 17-Jan-06 11:35 am
to what the doctor ordered!
Lannett Company Signs Exclusive Contract Manufacturing Agreement with Wintac Limited
Tuesday January 17, 7:15 am ET
Expands Pipeline with New Dosage Forms.
messages.finance.yahoo.com
messages.finance.yahoo.com
messages.finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext